Europlasma shows rollercoaster with 7% gain despite offerings
Europlasma stock rises 7% despite ongoing capital offerings, showing relative resilience.
Published 16sem1 sourceNotableupdated 3j
Lire en français
≈ 15s
The fact
The stock's pronounced volatility reflects contrasting investor expectations for the company.
Analysts remain divided on Europlasma's medium-term prospects.
Click the link to read an article on the topic: